Related Experiment Video
Updated: Apr 28, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
[Pseudomembranous colitis: pathogenesis, prevention, treatment].
This review covers the pathogenesis of Pseudomembranous colitis and Clostridium difficile-associated diarrhea (CDAD). It emphasizes evidence-based prevention and treatment strategies, focusing on rational antibiotic use.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Pharmacology
Background:
- Pseudomembranous colitis is primarily caused by Clostridium difficile.
- Antibiotic use is a major risk factor for Clostridium difficile-associated diarrhea (CDAD).
- Understanding pathogenesis is crucial for effective management.
Purpose of the Study:
- To review the pathogenesis of Pseudomembranous colitis.
- To outline evidence-based strategies for preventing and treating CDAD.
- To highlight the importance of rational antibiotic prescription.
Main Methods:
- Literature review focusing on pathogenesis, prevention, and treatment of CDAD.
- Emphasis on evidence-based medicine principles.
- Analysis of antibiotic stewardship in relation to CDAD.
Main Results:
- Detailed review of the mechanisms leading to Pseudomembranous colitis.
- Summarized evidence for various prevention and treatment modalities for CDAD.
- Highlighted the critical role of judicious antibiotic prescribing.
Conclusions:
- Effective management of Pseudomembranous colitis and CDAD requires understanding its pathogenesis.
- Evidence-based prevention and treatment guidelines should be implemented.
- Rational antibiotic use is paramount in reducing CDAD incidence and severity.
More Related Videos
08:34Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Related Concept Videos
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Diverticular Disease of the Colon
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD: